Larimar Therapeutics
LRMR
#6468
Rank
S$0.77 B
Marketcap
$12.09
Share price
-2.69%
Change (1 day)
272.00%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.27

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.23. In 2022 the company made an earnings per share (EPS) of -$2.06 an increase over its 2021 EPS that were of -$3.97.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.27-38.44%
2022-$2.06-48.15%
2021-$3.97-14.27%
2020-$4.63